Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)
- Conditions
- HIV-1 InfectionTreatment Resistant DisordersViremia
- Interventions
- First Posted Date
- 2014-09-25
- Last Posted Date
- 2015-10-12
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 4
- Registration Number
- NCT02247687
- Locations
- 🇫🇷
Hôpital Européen Georges Pompidou, France, France
🇫🇷Hôpital Avicenne, Bobigny, France
🇫🇷Hôpital Jean Verdier, Bondy, France
Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL
- First Posted Date
- 2014-08-08
- Last Posted Date
- 2021-04-27
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 170
- Registration Number
- NCT02212379
- Locations
- 🇫🇷
Hôpital Cochin, Paris, France
🇫🇷Hôpital Necker, Paris, France
🇫🇷Hôpital Croix Rousse, Lyon, France
Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan Africa
- Conditions
- Reproductive HealthHIVDisability
- First Posted Date
- 2014-07-17
- Last Posted Date
- 2016-07-12
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 1610
- Registration Number
- NCT02192658
4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients
- Conditions
- HIV-1 Infection
- Interventions
- Drug: Four consecutive days on treatment and 3 days off
- First Posted Date
- 2014-06-06
- Last Posted Date
- 2016-01-27
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 100
- Registration Number
- NCT02157311
- Locations
- 🇫🇷
Centre Hospitalier Sud Francilien, Corbeil Essonnes, France
🇫🇷Hôpital Meynard, Fort-de-france, Martinique, France
🇫🇷Hôpital Gui de Chauliac, Montpellier, France
First-Line Treatment for HIV-2
- Conditions
- HIV-2 Infection
- Interventions
- First Posted Date
- 2014-05-30
- Last Posted Date
- 2019-07-22
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 210
- Registration Number
- NCT02150993
- Locations
- 🇧🇫
CHU Sourô Sanou, Bobo-Dioulasso, Burkina Faso
🇨🇮Centre de Prise en Charge et de Formation (CePReF), Association ACONDA, Abidjan, Côte D'Ivoire
🇨🇮o L'Unité de soins ambulatoires et de conseils (USAC), CHU de Treichville, Abidjan, Côte D'Ivoire
Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection
- Conditions
- Viral Hepatitis CHIV
- Interventions
- Drug: Sofosbuvir/Ledipasvir fixed dose
- First Posted Date
- 2014-04-29
- Last Posted Date
- 2017-06-29
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 68
- Registration Number
- NCT02125500
- Locations
- 🇫🇷
Centre de Méthodologie et de Gestion de Rennes, Rennes, France
Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients
- Conditions
- HIV-1 Infection
- Interventions
- Other: Physiopathology study
- First Posted Date
- 2014-04-16
- Last Posted Date
- 2016-07-12
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 80
- Registration Number
- NCT02116374
- Locations
- 🇫🇷
Centre Henri Mondor, Creteil, France
🇫🇷Service de Médecine Interne et Immunologie Clinique, Le Kremlin Bicêtre, France
🇫🇷Service de maladies Infectieuses, Marseille, France
Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)
- Conditions
- Hepatitis C Virus Genotype 4 Infection
- Interventions
- First Posted Date
- 2014-04-08
- Last Posted Date
- 2017-01-24
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 60
- Registration Number
- NCT02107365
- Locations
- 🇫🇷
Hôpital Jean Verdier, Bondy, France
🇫🇷Hôpital de Haut Lévêque, Bordeaux Pessac, France
🇫🇷Hôpital Beaujon, Clichy, France
Evaluation of the National Treatment Program of Hepatitis C in Egypt
- Conditions
- Chronic Hepatitis C
- First Posted Date
- 2014-04-02
- Last Posted Date
- 2014-07-23
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Registration Number
- NCT02101177
- Locations
- 🇪🇬
NHTMRI, Cairo, Egypt
🇪🇬El Fahera El Fatemia, Cairo, Egypt
Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis C
- Conditions
- Chronic Hepatitis C
- Interventions
- Drug: Vitamin D + Pegylated Interferon Alpha 2b + Ribavirin
- First Posted Date
- 2014-03-31
- Last Posted Date
- 2017-07-12
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Registration Number
- NCT02099604
- Locations
- 🇪🇬
NHTMRI, Cairo, Egypt